These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31821365)

  • 21. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.
    Fraser H; Vellozzi C; Hoerger TJ; Evans JL; Kral AH; Havens J; Young AM; Stone J; Handanagic S; Hariri S; Barbosa C; Hickman M; Leib A; Martin NK; Nerlander L; Raymond HF; Page K; Zibbell J; Ward JW; Vickerman P
    Am J Epidemiol; 2019 Aug; 188(8):1539-1551. PubMed ID: 31150044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peer-to-peer injection: Demographic, drug use, and injection-related risk factors.
    Lamb S; Kral AH; Dominguez-Gonzalez K; Wenger LD; Bluthenthal RN
    Int J Drug Policy; 2018 Nov; 61():44-51. PubMed ID: 30388569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C transmission and treatment as prevention - The role of the injecting network.
    Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G
    Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.
    Tully DC; Hahn JA; Bean DJ; Evans JL; Morris MD; Page K; Allen TM
    Clin Infect Dis; 2022 Mar; 74(6):993-1003. PubMed ID: 34448809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.
    Jordan AE; Des Jarlais DC; Arasteh K; McKnight C; Nash D; Perlman DC
    Drug Alcohol Depend; 2015 Jul; 152():194-200. PubMed ID: 25891230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia.
    Tavitian-Exley I; Maheu-Giroux M; Platt L; Heimer R; Uusküla A; Levina O; Vickerman P; Boily MC
    Int J Drug Policy; 2018 Mar; 53():96-105. PubMed ID: 29306786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.
    Garfein RS; Doherty MC; Monterroso ER; Thomas DL; Nelson KE; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S11-9. PubMed ID: 9663618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Caballo": risk environments, drug sharing and the emergence of a hepatitis C virus epidemic among people who inject drugs in Puerto Rico.
    Abadie R; Dombrowski K
    Harm Reduct J; 2020 Oct; 17(1):85. PubMed ID: 33097062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine.
    Mazhnaya A; Tobin KE; Owczarzak J
    Drug Alcohol Depend; 2018 Aug; 189():125-130. PubMed ID: 29913323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillance.
    Gicquelais RE; Foxman B; Coyle J; Eisenberg MC
    Epidemics; 2019 Jun; 27():86-95. PubMed ID: 30930214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
    J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C infection and other drug-related harms among inpatients who injected drugs in Turkey.
    Alaei A; Alaei K; Waye K; Tracy M; Nalbandyan M; Mutlu E; Cetin MK
    J Viral Hepat; 2017 Jun; 24(6):496-505. PubMed ID: 27925346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners.
    Morris MD; Montgomery ME; Briceno A; Evans JL; Andrew EVW; Page K; Hahn JA
    Subst Use Misuse; 2018 Jul; 53(8):1281-1287. PubMed ID: 29286888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.